Fragile X: Developing targeted treatments

A new NeuroTherapeutics Research Institute will develop targeted treatments for neurodegenerative disorders, such as fragile X-associated tremor/ataxia syndrome, or FXTAS, discovered by UC Davis research team Randi and Paul Hagerman.

Back

Next